Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beta Bionics (BBNX) Cash from Operations (2024 - 2025)

Beta Bionics' Cash from Operations history spans 2 years, with the latest figure at 8627000.0 for Q4 2025.

  • For Q4 2025, Cash from Operations rose 39.58% year-over-year to 8627000.0; the TTM value through Dec 2025 reached 50925000.0, down 5.49%, while the annual FY2025 figure was 50925000.0, 5.49% down from the prior year.
  • Cash from Operations for Q4 2025 was 8627000.0 at Beta Bionics, up from 8729000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 8627000.0 in Q4 2025 and bottomed at 19975000.0 in Q1 2025.